Bodi Zhang

Bodi Zhang is the Chief Strategy Officer at Thorne HealthTech and a Venture Partner at NextGen Venture Partners. Bodi was a founding team member at Nutrativa and Onegevity Health, which were later acquired and merged with Thorne HealthTech. Bodi has a diverse background in healthcare management, venture capital, and research, with experience at organizations such as Deallus Consulting, Tufts University School of Medicine, and The Antibody Society. Bodi holds a Ph.D in Pharmacology and Immunology from Tufts University School of Medicine, a MPH in Healthcare Management from Harvard T.H. Chan School of Public Health, and a Medical Degree from Peking University. Additionally, Bodi has completed a Mini-MBA in Healthcare Venture Capital and Entrepreneurship from Harvard Business School.